GILD
Gilead Sciences Inc
149.70$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +23.6% | +2.3% | -40.3% | +225.2% | -31.0% | -40.9% | -52.9% | +396.7% | -19.0% | -23.5% | +40.4% | – | |
| – | +0.6% | +0.3% | +0.6% | -0.6% | +0.4% | +0.4% | -0.7% | -0.7% | +0.1% | +0.3% | -200.0% | – | |
| – | -0.5% | -7.0% | +12.3% | +2.9% | +2.8% | -5.9% | +7.7% | +2.2% | +0.0% | -5.2% | -200.0% | – | |
| – | – | – | – | – | -24.8% | -313.9% | – | – | – | – | – | – | |
| – | +76.2% | -51.2% | +23.8% | +8.5% | +4.3% | -29.3% | +2.9% | +37.4% | +39.5% | -42.9% | +0.0% | – | |
| – | +217.5% | +203.6% | -86.1% | +131.3% | -68.3% | +84.4% | +409.9% | -79.8% | +329.7% | – | -684.6% | – | |
| – | -1.0% | +5.0% | -1.8% | +1.1% | -1.0% | +3.8% | -1.6% | +1.1% | -1.1% | +4.6% | -1.1% | – | |
| – | -50.0% | +166.7% | -75.0% | +200.0% | +16.7% | +108.6% | -27.8% | -17.5% | -47.1% | +82.2% | -15.3% | – | |
| – | – | – | – | – | – | -151.0% | -99.5% | +0.0% | -11.1% | +34,475.0% | – | – | |
| – | -27.6% | +23.8% | +117.0% | -53.3% | – | -251.6% | -54.3% | -5.0% | -15.2% | +235.6% | – | – | |
| – | +37,900.0% | -459.7% | – | – | +118.7% | -141.7% | – | – | -89.3% | -72.6% | -7,051.6% | – | |
| – | +19.7% | +8.2% | -43.5% | +248.8% | -32.1% | -41.5% | -56.4% | +450.1% | -21.2% | -22.2% | +52.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.